[
  {
    "ts": null,
    "headline": "Regeneron: Recent Bear Run May Be Justified - Pharma Faces A Testing 2025",
    "summary": "Regeneron Pharmaceuticals, Inc.'s stock faces challenges with Eylea's decline but potential growth from Dupixent. Find out why I maintain a Hold rating on REGN.",
    "url": "https://finnhub.io/api/news?id=1f9517d7a0779e2ddac3fd37ad30058c41a2df850317a5a249aefaf783fe0746",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733509685,
      "headline": "Regeneron: Recent Bear Run May Be Justified - Pharma Faces A Testing 2025",
      "id": 131828747,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/172413295/image_172413295.jpg?io=getty-c-w1536",
      "related": "REGN",
      "source": "SeekingAlpha",
      "summary": "Regeneron Pharmaceuticals, Inc.'s stock faces challenges with Eylea's decline but potential growth from Dupixent. Find out why I maintain a Hold rating on REGN.",
      "url": "https://finnhub.io/api/news?id=1f9517d7a0779e2ddac3fd37ad30058c41a2df850317a5a249aefaf783fe0746"
    }
  },
  {
    "ts": null,
    "headline": "Regeneron Pharmaceuticals Inc. stock outperforms competitors on strong trading day",
    "summary": "Regeneron Pharmaceuticals Inc. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=c4de9b7d1ff8291a9ac3f823bf4f191cd7a0880c65e3da2c67797a2b82ac5256",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733503500,
      "headline": "Regeneron Pharmaceuticals Inc. stock outperforms competitors on strong trading day",
      "id": 131879510,
      "image": "",
      "related": "REGN",
      "source": "MarketWatch",
      "summary": "Regeneron Pharmaceuticals Inc. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=c4de9b7d1ff8291a9ac3f823bf4f191cd7a0880c65e3da2c67797a2b82ac5256"
    }
  },
  {
    "ts": null,
    "headline": "Law Offices of Howard G. Smith Continues Investigation of Regeneron Pharmaceuticals, Inc. (REGN) on Behalf of Investors",
    "summary": "BENSALEM, Pa., Dec. 6, 2024 /PRNewswire/ -- Law Offices of Howard G. Smith continues its investigation on behalf of Regeneron Pharmaceuticals, Inc. investors concerning the Company's possible...",
    "url": "https://finnhub.io/api/news?id=fe7fff4f2dfd75d27381bd0a6fe4616120940e7fb592f0e058da525591e454d6",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733486467,
      "headline": "Law Offices of Howard G. Smith Continues Investigation of Regeneron Pharmaceuticals, Inc. (REGN) on Behalf of Investors",
      "id": 131820955,
      "image": "",
      "related": "REGN",
      "source": "Finnhub",
      "summary": "BENSALEM, Pa., Dec. 6, 2024 /PRNewswire/ -- Law Offices of Howard G. Smith continues its investigation on behalf of Regeneron Pharmaceuticals, Inc. investors concerning the Company's possible...",
      "url": "https://finnhub.io/api/news?id=fe7fff4f2dfd75d27381bd0a6fe4616120940e7fb592f0e058da525591e454d6"
    }
  },
  {
    "ts": null,
    "headline": "Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?",
    "summary": "It is hard to get excited after looking at Regeneron Pharmaceuticals' (NASDAQ:REGN) recent performance, when its stock...",
    "url": "https://finnhub.io/api/news?id=a712125a4160c44db9f07d47c9fc50c3ad6e8a3b366acf08de9f1c8d604b87c5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733486426,
      "headline": "Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?",
      "id": 131822224,
      "image": "https://media.zenfs.com/en/simply_wall_st__316/2b615bb0216a492e754128412857f305",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "It is hard to get excited after looking at Regeneron Pharmaceuticals' (NASDAQ:REGN) recent performance, when its stock...",
      "url": "https://finnhub.io/api/news?id=a712125a4160c44db9f07d47c9fc50c3ad6e8a3b366acf08de9f1c8d604b87c5"
    }
  }
]